ARCHIVES

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

DCT board Oks New Cooperative Groups For MRI Evaluations In Breast Cancer

February 18, 1994

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007

NCI Formaldehyde Finding Criticized

March 7, 1986